These suggests that the modulation of BCL-6 function in TFH cells could be a potential strategy to enhance TFH cell resistance to retroviral infections and potentially decrease cellular reservoirs during HIV infection (15). This evidence concerns the gene BCL6 and HIV infectious disease.